Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or ...

Prof James Catto from the University of Sheffield described the findings as a "major breakthrough" in treating bladder cancer ...

Bladder cancer is among the top 10 most common cancer types in the world, with approximately 573,000 new cases annually. Men ...

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...

They were used on five patients, and four of them are now either in remission or cancer-free. Read more at straitstimes.com.

Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...

J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales ...

BladderPath trial found that patients with suspected invasive bladder cancer undergoing initial mpMRI were treated faster ...

According to Bladder Cancer UK, the main symptoms of bladder cancer are: ...

Researchers discover novel targets for bladder cancer therapeutics and demonstrate that a new combination of existing drugs, including statins, blocks tumor growth in mice.